| Name | myeloperoxidase |
| Description | Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of neutrophils. [provided by RefSeq, Nov 2014] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMyeloperoxidase (MPO) is a multifunctional enzyme best known for its critical role in innate immunity. In activated neutrophils, MPO catalyzes the formation of potent oxidants and works in concert with neutrophil elastase to mediate the decondensation of chromatin and formation of neutrophil extracellular traps (NETs). This process enables the trapping and killing of pathogens; conversely, complete MPO deficiency impairs NET formation and compromises antimicrobial defense."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its antimicrobial actions, MPO plays a significant role in regulating vascular homeostasis. Once released, MPO binds to and penetrates the endothelium, where its catalytic activity consumes nitric oxide, thereby impairing endothelium-dependent vasodilation. These effects contribute to oxidative stress during ischemia/reperfusion and are associated with adverse clinical outcomes in acute coronary syndromes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMPO also exerts a profound influence on lipoprotein metabolism and atherogenesis. By oxidatively modifying apolipoprotein A1, the chief protein of high‐density lipoprotein (HDL), MPO converts these normally cardioprotective particles into proinflammatory agents with impaired cholesterol efflux capabilities. Such modifications are believed to contribute to the development of dysfunctional HDL and promote plaque instability in atherosclerosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its roles in host defense and vascular regulation, MPO-generated oxidants mediate tissue injury in a range of pathological conditions. Aberrant expression of MPO in neurons and glial cells has been linked to neurodegenerative processes in Alzheimer’s disease, while its activity in other tissues contributes to inflammatory injury in conditions such as nonalcoholic steatohepatitis, multiple sclerosis, and MPO-ANCA–associated vasculitis. Moreover, MPO can modulate leukocyte lifespan by delaying apoptosis, further perpetuating inflammation. These diverse actions underscore MPO’s contribution to chronic tissue damage and immune dysregulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural and genetic studies of MPO have provided further insights into its function and potential as a therapeutic target. High-resolution analyses have detailed MPO’s active site architecture and halide binding dynamics, while investigations into natural autoantibodies and gene polymorphisms have illuminated links between MPO variants and susceptibility to conditions ranging from cancer to inflammatory disorders. Furthermore, MPO contained within neutrophil‐derived microparticles has been implicated in mediating endothelial injury, and targeted inhibition of MPO activity is emerging as a promising strategy to attenuate oxidative damage in cardiovascular and other inflammatory diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tim O Hirche, Joseph P Gaut, Jay W Heinecke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.174.3.1557"}], "href": "https://doi.org/10.4049/jimmunol.174.3.1557"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15661916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15661916"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kathleen D Metzler, Tobias A Fuchs, William M Nauseef, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-06-290171"}], "href": "https://doi.org/10.1182/blood-2010-06-290171"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20974672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20974672"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Venizelos Papayannopoulos, Kathleen D Metzler, Abdul Hakkim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201006052"}], "href": "https://doi.org/10.1083/jcb.201006052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20974816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20974816"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Heather Parker, Mike Dragunow, Mark B Hampton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.1211601"}], "href": "https://doi.org/10.1189/jlb.1211601"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22802447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22802447"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Daigo Nakazawa, Haruki Shida, Utano Tomaru, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2013060606"}], "href": "https://doi.org/10.1681/ASN.2013060606"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24385592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24385592"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jason P Eiserich, Stephan Baldus, Marie-Luise Brennan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase, a leukocyte-derived vascular NO oxidase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1106830"}], "href": "https://doi.org/10.1126/science.1106830"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12089442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12089442"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Stephan Baldus, Thomas Heitzer, Jason P Eiserich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2004.06.003"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2004.06.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15304260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15304260"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Stephan Baldus, Volker Rudolph, Mika Roiss, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.105.590083"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.105.590083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16606792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16606792"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Giuseppe Ferrante, Masataka Nakano, Francesco Prati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.110.955302"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.110.955302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21126969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21126969"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Baohai Shao, Michael N Oda, Constanze Bergt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C600011200"}], "href": "https://doi.org/10.1074/jbc.C600011200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16497665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16497665"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Arundhati Undurti, Ying Huang, Joseph A Lupica, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.047605"}], "href": "https://doi.org/10.1074/jbc.M109.047605"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19726691"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19726691"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Baohai Shao, Michael N Oda, John F Oram, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chem Res Toxicol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/tx9003775"}], "href": "https://doi.org/10.1021/tx9003775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20043647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20043647"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Baohai Shao, Subramaniam Pennathur, Jay W Heinecke "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.337345"}], "href": "https://doi.org/10.1074/jbc.M111.337345"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22219194"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22219194"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ying Huang, Zhiping Wu, Meliana Riwanto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI67478"}], "href": "https://doi.org/10.1172/JCI67478"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23908111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23908111"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Pattie S Green, Armando J Mendez, Jason S Jacob, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal expression of myeloperoxidase is increased in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1471-4159.2004.02527.x"}], "href": "https://doi.org/10.1111/j.1471-4159.2004.02527.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15255951"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15255951"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Timothy S McMillen, Jay W Heinecke, Renee C LeBoeuf "}, {"type": "b", "children": [{"type": "t", "text": "Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.104.516278"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.104.516278"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15911707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15911707"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Joshua Millstein, David V Conti, Frank D Gilliland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A testing framework for identifying susceptibility genes in the presence of epistasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/498850"}], "href": "https://doi.org/10.1086/498850"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16385446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16385446"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yi Wang, Henry Rosen, David K Madtes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M704894200"}], "href": "https://doi.org/10.1074/jbc.M704894200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17726014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17726014"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Elizabeth Gray, Taya L Thomas, Samar Betmouni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Pathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1750-3639.2007.00110.x"}], "href": "https://doi.org/10.1111/j.1750-3639.2007.00110.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18042261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18042261"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Driss El Kebir, Levente József, Wanling Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000326772.76822.7a"}], "href": "https://doi.org/10.1161/01.RES.0000326772.76822.7a"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18617697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18617697"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Richard A Maki, Vladimir A Tyurin, Robert C Lyon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M807731200"}], "href": "https://doi.org/10.1074/jbc.M807731200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19059911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19059911"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Sander S Rensen, Yanti Slaats, Jeroen Nijhuis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2009.080999"}], "href": "https://doi.org/10.2353/ajpath.2009.080999"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19729473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19729473"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Juergen Arnhold, Joerg Flemmig "}, {"type": "b", "children": [{"type": "t", "text": "Human myeloperoxidase in innate and acquired immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2010.04.008"}], "href": "https://doi.org/10.1016/j.abb.2010.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20399194"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20399194"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Zhao Cui, Ming-hui Zhao, Mårten Segelmark, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ki.2010.198"}], "href": "https://doi.org/10.1038/ki.2010.198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20592714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20592714"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Piotr Gałecki, Elżbieta Gałecka, Michael Maes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Affect Disord (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jad.2012.01.016"}], "href": "https://doi.org/10.1016/j.jad.2012.01.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22331023"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22331023"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Akiko Yokoseki, Etsuji Saji, Musashi Arakawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awt314"}], "href": "https://doi.org/10.1093/brain/awt314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24271323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24271323"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "M Blair-Johnson, T Fiedler, R Fenna "}, {"type": "b", "children": [{"type": "t", "text": "Human myeloperoxidase: structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 A resolution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi0111808"}], "href": "https://doi.org/10.1021/bi0111808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11705390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11705390"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Maja Krajinovic, Hugues Sinnett, Chantal Richer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.1589"}], "href": "https://doi.org/10.1002/ijc.1589"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11774269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11774269"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Maja Krajinovic, Damian Labuda, Geraldine Mathonnet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11895912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11895912"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Vanderson Rocha, Rendrik F Franco, Raphael Porcher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-04-1033"}], "href": "https://doi.org/10.1182/blood-2002-04-1033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12393699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12393699"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jeffrey P Henderson, Jaeman Byun, Junko Takeshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M303928200"}], "href": "https://doi.org/10.1074/jbc.M303928200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12707270"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12707270"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Stephan Baldus, Christopher Heeschen, Thomas Meinertz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.CIR.0000090690.67322.51"}], "href": "https://doi.org/10.1161/01.CIR.0000090690.67322.51"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12952835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12952835"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Valerian E Kagan, Nagarjun V Konduru, Weihong Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Nanotechnol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nnano.2010.44"}], "href": "https://doi.org/10.1038/nnano.2010.44"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20364135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20364135"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "A V Marzano, M Cugno, V Trevisan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2249.2010.04201.x"}], "href": "https://doi.org/10.1111/j.1365-2249.2010.04201.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20636397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20636397"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Anna-Karin Tidén, Tove Sjögren, Mats Svensson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.266981"}], "href": "https://doi.org/10.1074/jbc.M111.266981"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21880720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21880720"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Thassila Nogueira Pitanga, Luciana de Aragão França, Viviane Costa Junqueira Rocha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2121-15-21"}], "href": "https://doi.org/10.1186/1471-2121-15-21"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24915973"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24915973"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Nathaniel Teng, Ghassan J Maghzal, Jihan Talib, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/13510002.2016.1256119"}], "href": "https://doi.org/10.1080/13510002.2016.1256119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27884085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27884085"}]}]}]}
|
| Proteins | PERM_HUMAN |
| NCBI Gene ID | 4353 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MPO has 13,923 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 124 datasets.
Click the + buttons to view associations for MPO from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by MPO gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MPO gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MPO gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MPO gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MPO gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MPO gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MPO gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving MPO protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MPO gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MPO gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MPO gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MPO gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MPO gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MPO gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MPO gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MPO gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MPO gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MPO gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with MPO gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MPO gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing MPO protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MPO gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MPO protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MPO protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MPO protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MPO protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MPO gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MPO gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MPO gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MPO gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MPO gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MPO gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MPO gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MPO gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MPO gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MPO gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for MPO protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MPO gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MPO gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MPO gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MPO from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MPO gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MPO gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MPO gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MPO gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MPO from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MPO gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding MPO protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MPO gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MPO gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MPO gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MPO protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MPO protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MPO protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MPO gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MPO gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MPO gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MPO gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MPO gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MPO gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with MPO gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with MPO gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MPO gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for MPO protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MPO gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MPO protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MPO gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of MPO protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with MPO gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MPO from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with MPO gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with MPO gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with MPO gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MPO gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MPO protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MPO gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MPO gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MPO gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving MPO protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving MPO protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MPO gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MPO gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MPO gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MPO gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MPO gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MPO protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MPO protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MPO gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MPO gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MPO gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MPO gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MPO gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NURSA Protein Complexes | protein complexs containing MPO protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| NURSA Protein-Protein Interactions | interacting proteins for MPO from the NURSA Protein-Protein Interactions dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MPO gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MPO from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MPO gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MPO gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MPO protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MPO protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving MPO protein from the PID Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MPO protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MPO gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MPO gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MPO gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MPO gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MPO protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of MPO gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MPO gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MPO gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MPO gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MPO protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MPO protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MPO protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MPO protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MPO protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MPO protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving MPO protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MPO protein from the WikiPathways Pathways 2024 dataset. | |